# FDA Inspection 1216086 - Fresenius Kabi iPSUM S.r.l.. - June 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/fresenius-kabi-ipsum-srl/f396d7d7-7d5b-4e2a-8764-bba34c016e69
Source feed: FDA_Inspections

> FDA Inspection 1216086 for Fresenius Kabi iPSUM S.r.l.. on June 24, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216086
- Company Name: Fresenius Kabi iPSUM S.r.l..
- Inspection Date: 2022-06-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1159228 - 2018-07-27](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-ipsum-srl/65e74418-dffa-43e0-96ee-80765668d028)
- [FDA Inspection 784203 - 2012-03-22](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-ipsum-srl/c990295c-9724-462f-86a2-148df6731dc6)

Company: https://www.keypedia.com/companies/fresenius-kabi-ipsum-srl/f63d0d20-5e33-4c35-ae06-8f74df07c726

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c